Elevated abeta42 in skeletal muscle of Alzheimer disease patients suggests peripheral alterations of AbetaPP metabolism.
about
Origins of amyloid-βHow citation distortions create unfounded authority: analysis of a citation networkA systematic review and meta-analysis of plasma amyloid 1-42 and tau as biomarkers for Alzheimer's diseaseFamilial Alzheimer's disease mutations inhibit gamma-secretase-mediated liberation of beta-amyloid precursor protein carboxy-terminal fragmentMRI and CSF studies in the early diagnosis of Alzheimer's disease.The human amyloid-beta precursor protein770 mutation V717F generates peptides longer than amyloid-beta-(40-42) and flocculent amyloid aggregates.Identification of a new presenilin-dependent zeta-cleavage site within the transmembrane domain of amyloid precursor protein.A novel nicotinic acetylcholine receptor subtype in basal forebrain cholinergic neurons with high sensitivity to amyloid peptidesTreadmill exercise ameliorates the regulation of energy metabolism in skeletal muscle of NSE/PS2m-transgenic mice with Alzheimer's disease.Chemical characterization of pro-inflammatory amyloid-beta peptides in human atherosclerotic lesions and platelets.Inclusion body myositis-like phenotype induced by transgenic overexpression of beta APP in skeletal muscle.Age-associated evolution of plasmatic amyloid in mouse lemur primates: relationship with intracellular amyloid deposition.Caffeine protects against disruptions of the blood-brain barrier in animal models of Alzheimer's and Parkinson's diseases.Mitochondrial oxygen consumption deficits in skeletal muscle isolated from an Alzheimer's disease-relevant murine modelRole of amyloid peptides in vascular dysfunction and platelet dysregulation in Alzheimer's diseasePlasma amyloid-β as a function of age, level of intellectual disability, and presence of dementia in Down syndrome.Age-dependent biochemical dysfunction in skeletal muscle of triple-transgenic mouse model of Alzheimer`s disease.Measurement of altered AβPP isoform expression in frontal cortex of patients with Alzheimer's disease by absolute quantification real-time PCRArizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program.Presenilin-1 280Glu-->Ala mutation alters C-terminal APP processing yielding longer abeta peptides: implications for Alzheimer's diseaseThe Sun Health Research Institute Brain Donation Program: description and experience, 1987-2007Maximizing the potential of plasma amyloid-beta as a diagnostic biomarker for Alzheimer's disease.Role of Endolysosomes in Skeletal Muscle Pathology Observed in a Cholesterol-Fed Rabbit Model of Alzheimer's Disease.Neurochemical dementia diagnostics: State of the art and research perspectives.Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's disease.Neurochemical dementia diagnostics: assays in CSF and blood.Gamma-secretase catalyzes sequential cleavages of the AbetaPP transmembrane domain.Plasma amyloid-β levels and prognosis in incident dementia cases of the 3-City StudyNeurochemical dementia diagnostics in Alzheimer's disease: where are we now and where are we going?Expression and function of APP and its metabolites outside the central nervous system.Expression and Processing of Amyloid Precursor Protein in Vascular Endothelium.Having a Coffee Break: The Impact of Caffeine Consumption on Microglia-Mediated Inflammation in Neurodegenerative Diseases.Amyloid beta(1-42) peptide alters the gating of human and mouse alpha-bungarotoxin-sensitive nicotinic receptors.APP/Aβ structural diversity and Alzheimer's disease pathogenesis.Biophysical characterization of longer forms of amyloid beta peptides: possible contribution to flocculent plaque formation.Aβ Amyloid Pathology Affects the Hearts of Patients With Alzheimer's Disease: Mind the Heart.Blood-derived amyloid-β protein induces Alzheimer's disease pathologies.Potential link between amyloid beta-protein 42 and C-terminal fragment gamma 49-99 of beta-amyloid precursor protein.Amyloid-beta-induced toxicity of primary neurons is dependent upon differentiation-associated increases in tau and cyclin-dependent kinase 5 expression.[The future of biomarkers in dementia diagnostics].
P2860
Q21266674-817E7125-6FFB-4861-8C5E-04F8DC131C02Q24260685-96A5DCC9-85F5-4A38-9A44-E797887617DAQ26771808-2B98AD26-B0A9-4494-8BF4-686AB4A63765Q28259354-6DA77922-B5BF-425E-9A6F-789E0F959914Q30953178-82A40204-0BD1-434D-A739-01A5C6D2F34CQ31029600-4060DE29-84DF-4AD6-B2E7-1627B527D441Q33207923-F00FDEDB-B9FC-453B-BF52-470F4BFC0CF6Q33801299-5256B73A-448A-48CF-A058-EFCDCC738982Q33899674-A1E32AC6-59C1-44A9-BB65-736F89054E29Q33969588-74BD19EA-D3C2-4D23-B881-94C357497BF4Q34029128-93E7F7FD-FF1E-49F0-89AA-C977953FB584Q34716790-E4512484-6C9B-4E44-B819-3FA3714775FDQ34905120-969F4A44-54B5-436D-8CC8-6A5252A77B85Q35093852-C3F7A531-2939-4858-8C91-A3B296C33C0CQ35141182-D452E4CD-9DC7-4634-AB17-56CF58916ECAQ35559097-C8E460AD-8971-4672-8165-D7DA7FD0AC88Q35596754-7760CB9E-9F39-48AE-BA15-75555B959BCDQ35886927-28B4ECE3-5B6B-47C8-80B2-B7FFE3F3754EQ36121377-D3930381-294A-447C-A00F-70685EF57A58Q36481949-9F2DF163-378C-4071-A5DD-A5F36348989FQ36805238-FA365CCA-2CE3-44CC-BF27-01F6FE629092Q36919081-51473104-3642-47DA-B117-C15114D6DDD8Q36978700-54CD32DE-8E55-4A0B-BF64-7C00DE54D22AQ37083439-62BCF038-CF2A-49B9-9314-CA38D67B9D84Q37145570-E448AB43-D7CD-4F95-B64E-6A59ACDB2980Q37317868-EE19B47C-A241-45CA-A8F4-2E35E0497474Q37394529-503E91F8-30CA-4562-BE3E-B9C02BC697F1Q37693190-22E51994-CA05-4C70-BA61-B483F82A92EEQ37912199-7A9410E6-5EEF-4013-93A2-1ED1C7D304F1Q38030678-3C9449FB-9E4B-4C04-AA34-AA58D2DDF4A9Q39032252-175394AF-8E26-40C7-9834-9406A586191FQ39157059-8BFDBF81-5A87-4F31-BB61-A55A9D97922FQ40673378-84E7FAA5-E291-45A0-8E31-D0A2B255CD6FQ46320596-DBE899F0-2853-4C42-BA6D-B0B0E3ED51E9Q46814171-E84D49AF-1CC3-4AC1-ADE9-ABB711BBE5EAQ47094954-6B3969C1-A43B-4609-967F-E74D9F726F1CQ47584093-BF18015D-D2E3-4846-ACA1-F20AF338A3C7Q51837859-B51EB583-6F63-4905-97DB-07539BDD897FQ52552907-41F5E531-EFDF-45DD-A9CE-98861B70A508Q53322182-18A15BA9-FAF9-48CD-B62C-1650A57D9C6B
P2860
Elevated abeta42 in skeletal muscle of Alzheimer disease patients suggests peripheral alterations of AbetaPP metabolism.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Elevated abeta42 in skeletal m ...... rations of AbetaPP metabolism.
@ast
Elevated abeta42 in skeletal m ...... rations of AbetaPP metabolism.
@en
type
label
Elevated abeta42 in skeletal m ...... rations of AbetaPP metabolism.
@ast
Elevated abeta42 in skeletal m ...... rations of AbetaPP metabolism.
@en
prefLabel
Elevated abeta42 in skeletal m ...... rations of AbetaPP metabolism.
@ast
Elevated abeta42 in skeletal m ...... rations of AbetaPP metabolism.
@en
P2093
P2860
P1476
Elevated abeta42 in skeletal m ...... erations of AbetaPP metabolism
@en
P2093
M D Watson
M R Emmerling
R J Cotter
T A Kokjohn
W M Kalback
P2860
P304
P356
10.1016/S0002-9440(10)64947-4
P407
P50
P577
2000-03-01T00:00:00Z